Aliaksandr Prokharau

Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial

Kohei Shitara, Toshihiko Doi, Mikhail Dvorkin et al. · The Lancet Oncology · 2018 · 495 citations

Gastrointestinal Oncology, Trifluridine/tipiracil Versus Placebo, Medicine +9

Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial

Won Seog Kim, Christian Buske, Michinori Ogura et al. · The Lancet Haematology · 2017 · 74 citations · Full text

Lymphoid Neoplasia, Advanced-stage Follicular Lymphoma, Medicine +9

Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy

David H. Ilson, Josep Tabernero, Aliaksandr Prokharau et al. · JAMA Oncology · 2019 · 19 citations · Full text

Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS

Josep Tabernero, María Alsina, Kohei Shitara et al. · Gastric Cancer · 2020 · 18 citations · Full text

Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)

Bertrand Coiffier, Juan‐Manuel Sancho, Wojciech Jurczak et al. · Blood · 2016 · 13 citations